The Valens Co

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Valens Groworks is a biotechnology company that specializes in cannabis extraction, testing, analytics, and manufacturing. It focused on being the partner of choice for Canadian and international cannabis brands by providing proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, and white-label product development. The company provides diverse extraction methods to develop premium products based on their needs. The Valens Groworks seeks to capture a broad spectrum of medical cannabis users, and adult recreational users once legalized, as well as clinical trial and R&D clients, in pursuit of its ambitious seed-to-sale and farm-to-pharma objectives. The company was founded in 2010 and headquartered in Kelowna, British Columbia.

The Valens Company (TSX:VLNS, OTCQX:VLNCF) has updated its shareholders on the rationale behind its recent US$28.75 million bought deal financing and on its “integration initiatives”.  In a letter to shareholders, the manufacturer of cannabis products, which announced the first wave of integration initiatives in early February, unveiled a second wave of initiatives which are aimed at delivering additional operational and organizational efficiencies in the coming quarters as Valens “continues on its path to profitability”.

Valens Company updates shareholders on financing rationale and integration initiatives as it continues on its path to profitability

KELOWNA, BC , April 5, 2022 /PRNewswire/ -  The Valens Company Inc.  (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today released the following letter to shareholders from the Company's Chief Executive Officer, Tyler Robson, and President, Jeff Fallows outlining the rationale for the recent financing. The letter also provides an update on the first wave of integration initiatives announced in early February and introduces a second wave of initiatives which are aimed at delivering additional operational and organizational efficiencies in the coming quarters as the Company continues on its path to profitability.

The Valens Company Issues Letter to Shareholders & Announces Initiation of Second Wave of Integration Initiatives to Increase Efficiencies and Drive Additional Cost Savings

The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc has announced the closing of its previously announced bought deal public offering of units for total gross proceeds of approximately C$32.3 million.  The company said it sold 12,205,186 units at a price of C$2.65 each, including 1,591,979 units sold under the exercise of the underwriters' over-allotment option.

The Valens Company closes previously announced bought deal public offering of units for total gross proceeds of approximately C$32.3M

KELOWNA, BC, April 5, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce the closing of its previously announced bought deal public offering (the "Offering") of units of the Company (the "Units") for total gross proceeds of approximately CDN$32.3 million. The Company sold 12,205,186 Units at a price of CDN$2.65 per Unit, including 1,591,979 Units sold pursuant to the exercise of the underwriters' over-allotment option.

The Valens Company Closes Previously Announced Bought Deal Financing Including Exercise of Over-Allotment Option

Canopy Growth

Greenlane Holdings

High Tide

IM Cannabis Corp

SNDL Inc.

Urban-gro

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.

7 Cannabis Stocks in Focus; All Eyes on Decriminalization Bill

The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc said it has entered into an agreement with Stifel Nicolaus Canada Inc and AGP/Alliance Global Partners, on behalf of a syndicate of underwriters, for a  'bought deal' offering to raise aggregate gross proceeds of C$28.125 million, or approximately US$22.5 million. The company said it plans to use the net proceeds from the offering to continue to pursue strategic growth initiatives in North America, provide financing for working capital and for general corporate purposes.

The Valens Company inks agreement for a  'bought deal' offering to raise aggregate gross proceeds of C$28.125 million

Allego NV

AMC Entertainment

FAT Brands

GameStop

IGM Biosciences Inc

PureCycle Technologies

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore, and bring order to the markets.

8 Stocks Halted In Tuesday's Session

Agrify

Akanda Corp

Flora Growth Corp

Innovative Industrial Properties

Chicago Atlantic Real Estate Finance

Tilray Brands

10 Smoking Hot Cannabis Stocks to Keep on Your Radar

The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc, a leading manufacturer of cannabis products, said it has continued to grow its share of Canada's recreational market and said it expects further growth in the coming quarters.  The company said its share of the national market rose to 3.1% in February 2022 from 2.4% in November 2021, raising its market ranking to 10th from 12th.

Valens Company reports continued growth in market share

KELOWNA, BC, March 16, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS)) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to provide an update on its recent recreational market share in Canada. Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company, said "We have shown strong quarter-over-quarter growth, as we continue to execute on our business strategy across all our brands in the Canadian recreational market.

The Valens Company Continues to Grow National Market Share

AFC Gamma

Incannex Healthcare Inc

Village Farms International

The 7 Hottest Cannabis Stocks To Watch This Week

OrganiGram Holdings Inc.

Top Penny Pot Stocks For Your List In MArch The post Taking Advantage Of Market Volatility? 3 Marijuana Penny Stocks To Watch In March appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Taking Advantage Of Market Volatility? 3 Marijuana Penny Stocks To Watch In March

Clever Leaves Holdings Inc

Cronos Group

GrowGeneration Corp

Hydrofarm Holdings Group

Jazz Pharmaceuticals

Zynerba Pharmaceuticals

Cannabis Sector Kicks Off March With a Blast of Q4 Earnings

The Valens Company Inc. (VLNS) CEO Tyler Robson on Q4 2021 Results - Earnings Call Transcript

The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc has told investors it is seeing strong momentum across all key segments in the first quarter of 2022, as the cannabis-focused group posted fourth quarter and full-year fiscal 2021 results to end-November. The company said recent cost-saving and integration measures had placed it on the 'path towards profitability' and it expects to achieve both positive adjusted EBITDA by the fourth quarter this year and revenue guidance for fiscal 2023 of at least C$225 million.

The Valens Company says it is on path towards being EBITDA positive by fiscal fourth quarter this year

Provincial sales net revenue increased 31.7% to $7.9 million in Q4 2021 compared to $6.0 million in Q3 2021 Canada-wide provincial listings increased 21.0% to 219 in Q4 2021, compared to 181 in Q3 2021, with further growth to 255 as of January 30, 2022 Adjusted gross profit margin increased significantly to 34.1% in Q4 2021 compared to 27.4% in Q3 2021 B2C revenue lines of provincial sales and Green Roads accounted for 73.9% of net revenue in Q4 2021 Valens expects to achieve positive adjusted EBITDA by Q4 2022 KELOWNA, BC, Feb. 28, 2022 /PRNewswire/ -  The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to report its fourth quarter and fiscal year financial results for the period ended November 30, 2021. Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company, said: "This quarter showcases the progress we have made in our business plan in key areas despite a competitive and challenging operating environment in Canada and globally.

The Valens Company Reports Fourth Quarter and Fiscal Year 2021 Financial Results

KELOWNA, BC, Feb. 17, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce it will issue its fourth quarter and fiscal year 2021 financial results for the period ended November 30, 2021, on Monday, February 28, 2022, after market close. CONFERENCE CALL DETAILS The Company will host a conference call the following day, Tuesday, March 1, 2022 at 11:00 am Eastern Time / 8:00 am Pacific Time to discuss the financial results and business outlook.

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2021

The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc announced it had successfully commissioned and completed its first shipments of its Pommies beverage from its manufacturing facility in the Toronto area. The first shipment was shipped to Ontario at the end of January and purchase orders for British Columbia, Alberta Manitoba, and Yukon are expected to be fulfilled in the coming days, the company said in a statement.

The Valens Company ships first batch of beverages from its Greater Toronto Area manufacturing facility; inks beverage manufacturing partnership

The first shipment of beverages has shipped to Ontario and purchase orders for British Columbia, Alberta Manitoba, and Yukon are expected to be fulfilled in the coming days KELOWNA, BC, Feb. 10, 2022 /PRNewswire/ - The Valens Company Inc.  (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced the successful commissioning and completion of first shipments from Pommies (otherwise known as Southern Cliff Brands) located in the Greater Toronto Area (the "GTA Facility"). The 30,000 square feet GTA Facility received a micro-processing license from Health Canada to begin production and manufacturing of cannabis-infused beverages in November 2021.

The Valens Company Begins Manufacturing Cannabis-Infused Beverages at Greater Toronto Area Facility & Signs Manufacturing Partnership

Stifel GMP has repeated its 'Buy' rating on The Valens Company (TSX:VLNS, OTCQX:VLNCF) with a target price of C$5.25 due to its greater confidence in the company's ability to endure near-term headwinds. In a note to clients, the broker's analysts said they also came away from an investor day more comfortable with Valens' new guidance that it will reach profitability by the fourth quarter of fiscal 2022 and generate $225 million in full-year sales in 2023 at a 10% EBITDA margin.

Stifel GMP repeats 'Buy' on The Valens Company on its ability to endure near-term headwinds and reach profitability

The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc announced integration initiatives aimed at driving revenue growth and market share gains for each of its portfolio brands in their target markets, as well as margin improvement through more efficient operations, reduced operational and organizational costs and realization of M&A-related synergies following an acquisitive 2021. The company said that the next phases of its 'Launch, Grow, Optimize' strategy is well underway after a highly successful 'Launch' phase that positioned Valens as a leading cannabis consumer products company.

The Valens Company announces integrative initiative; identifies $10M in annual cost efficiencies

The next phases of its 'Launch, Grow, Optimize' strategy are well underway after a highly successful 'Launch' phase that positioned Valens as a leading cannabis consumer products company Optimization strategies are underway and $10 million in annual cost efficiencies have been identified through operational process efficiency gains, reductions in manufacturing and sourcing costs, organizational realignment and realization of M&A synergies The company anticipates identifying an additional $10 million in annual cost efficiencies and implementing them by the end of 2022 KELOWNA, BC, Feb. 2, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce integration initiatives aimed at driving revenue growth and market share gains for each of its portfolio brands in their target markets, as well as margin improvement through more efficient operations, reduced operational and organizational costs and realization of M&A-related synergies following an acquisitive 2021. As Valens now enters the 'Grow & Optimize' phases of its 'Launch, Grow, Optimize' strategy, the Company will be focusing on four key pillars: Driving revenue growth with a focus on Canadian recreational and U.S. health and wellness markets Capturing market share across its brand portfolio in product categories of focus that include flower, vape, pre-roll, edible, and beverage offerings in the premium, accessible premium, and value segments Seeking to generate increased gross margins and positive EBITDA margins through revenue growth and cost reduction and efficiency initiatives aimed at keeping operations flexible and innovative Creating shareholder value through operational performance, financial transparency, and increased trading liquidity "It's a pivotal time for Valens after a very acquisitive 2021 that saw us accelerate our business plan from three years to one and create a leading cannabis consumer products company with an exciting portfolio of brands," said Tyler Robson, Chief Executive Officer and Chairman of The Valens Company.

The Valens Company Announces Integration Initiative After Acquisitive 2021

The Vaelns Company VLNS VLNS  a manufacturer of cannabis products, will host a virtual Investor Day on February 7, 2022, at 11:00 AM ET. Registration for the webcast will start at 10:45 AM ET and the presentation will begin at 11:00 AM ET.

The Valens Company To Host Virtual Investor Day

KELOWNA, BC, Jan. 31, 2022 /PRNewswire/ -  The Valens Company Inc.  (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce that it will host a virtual Investor Day on February 7, 2022, at 11:00 AM ET. Registration for the webcast will start at 10:45 AM ET and the presentation will begin at 11:00 AM ET.

The Valens Company to Host Investor Day

Akerna Corp

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is shaping up as we kick off 2022.

One Extremely Hot Week in Cannabis Stocks Wraps up January

News for The Valens Co Stock (VLNS)